View in EDS

A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis.

Saved in:
Bibliographic Details
Title: A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis.
Authors: Lee HC; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Becnel MR; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA., Pasvolsky O; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Murga A; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Johnson RJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Thomas SK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Steiner R; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Iyer SP; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Weber DM; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Patel KK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Kaufman GP; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA., Manasanch EE; GlaxoSmithKline, Philadelphia, Pennsylvania, USA., Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Source: American journal of hematology [Am J Hematol] 2026 Jun; Vol. 101 (6), pp. 1187-1191. Date of Electronic Publication: 2026 Feb 19.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41714853
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+HC%22">Lee HC</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Becnel+MR%22">Becnel MR</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Feng+L%22">Feng L</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Pasvolsky+O%22">Pasvolsky O</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Murga+A%22">Murga A</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+RJ%22">Johnson RJ</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+SK%22">Thomas SK</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Bashir+Q%22">Bashir Q</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Qazilbash+MH%22">Qazilbash MH</searchLink>; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Steiner+R%22">Steiner R</searchLink>; Memorial Sloan Kettering Cancer Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Iyer+SP%22">Iyer SP</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Weber+DM%22">Weber DM</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Patel+KK%22">Patel KK</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Kaufman+GP%22">Kaufman GP</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.<br /><searchLink fieldCode="AU" term="%22Manasanch+EE%22">Manasanch EE</searchLink>; GlaxoSmithKline, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Orlowski+RZ%22">Orlowski RZ</searchLink>; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2026 Jun; Vol. 101 (6), pp. 1187-1191. <i>Date of Electronic Publication: </i>2026 Feb 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41714853
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ajh.70239
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1187
    Titles:
      – TitleFull: A Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in AL Amyloidosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee HC
      – PersonEntity:
          Name:
            NameFull: Becnel MR
      – PersonEntity:
          Name:
            NameFull: Feng L
      – PersonEntity:
          Name:
            NameFull: Pasvolsky O
      – PersonEntity:
          Name:
            NameFull: Murga A
      – PersonEntity:
          Name:
            NameFull: Johnson RJ
      – PersonEntity:
          Name:
            NameFull: Thomas SK
      – PersonEntity:
          Name:
            NameFull: Bashir Q
      – PersonEntity:
          Name:
            NameFull: Qazilbash MH
      – PersonEntity:
          Name:
            NameFull: Steiner R
      – PersonEntity:
          Name:
            NameFull: Iyer SP
      – PersonEntity:
          Name:
            NameFull: Weber DM
      – PersonEntity:
          Name:
            NameFull: Patel KK
      – PersonEntity:
          Name:
            NameFull: Kaufman GP
      – PersonEntity:
          Name:
            NameFull: Manasanch EE
      – PersonEntity:
          Name:
            NameFull: Orlowski RZ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1096-8652
          Numbering:
            – Type: volume
              Value: 101
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: American journal of hematology
              Type: main
ResultId 1